ClinConnect ClinConnect Logo
Search / Trial NCT06748976

Modulation of Cortical Brain Activity During Attentional Control

Launched by NATIONAL COUNCIL OF SCIENTIFIC AND TECHNICAL RESEARCH, ARGENTINA · Dec 19, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Operant Conditioning Rumination Metacognition Neurofeedback Selective Attention

ClinConnect Summary

This clinical trial, titled "Modulation of Cortical Brain Activity During Attentional Control," is studying how a special type of feedback, called sham neurofeedback, might help improve focus and attention in people dealing with conditions like chronic pain and fibromyalgia. The researchers want to see if using this feedback in a virtual reality setting can change certain brain activity patterns, specifically EEG alpha rhythms, which are related to how our attention is managed. Participants will experience three different scenarios: one where they receive positive feedback, one with negative feedback, and one without any feedback at all. By comparing these experiences, the study aims to understand if and how this feedback can help people enhance their attention.

To participate, individuals should be adults aged 18 to 60 years with normal or corrected vision and the ability to agree to take part in the study by signing a consent form. However, those with certain conditions, like epilepsy, significant hearing loss, current psychiatric illnesses, or who are pregnant, cannot join. Participants will wear a virtual reality headset and have their brain activity measured during the sessions, but they will first go through a pilot session to ensure they are comfortable with the equipment. This study is not yet recruiting, but it promises to explore new ways to help individuals struggling with focus and attention issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged between 18 and 60 years.
  • Normal or corrected vision.
  • Ability to provide written informed consent.
  • Exclusion Criteria:
  • Diagnosed with photosensitive epilepsy.
  • Significant hearing loss or diagnosed hearing impairment.
  • Current psychiatric illness or disorder.
  • History of migraines or chronic headaches.
  • History of substance or alcohol abuse.
  • Currently pregnant.
  • Discomfort with using a virtual reality headset, assessed during a pilot session.

About National Council Of Scientific And Technical Research, Argentina

The National Council of Scientific and Technical Research (CONICET) in Argentina is an esteemed governmental agency dedicated to advancing scientific knowledge and technological innovation. Established to promote research in various fields, CONICET plays a pivotal role in fostering collaboration between academic institutions and industry, ensuring the application of scientific findings to enhance societal well-being. With a strong focus on multidisciplinary research, the council supports clinical trials that aim to address pressing health challenges, contributing to the development of evidence-based medical practices and therapies. Through its commitment to excellence in research, CONICET is instrumental in positioning Argentina as a leader in scientific inquiry and innovation on the global stage.

Locations

Oro Verde, Entre Ríos, Argentina

Oro Verde, , Argentina

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported